Map | A Partnership for Children's Health Search:  Advanced Search
Home General Information Country Support Board Task Forces Resources Media Center
About the Board Last Board Meeting Members Board Reports EC reports Private Access
Printer-friendly format

Quick Reference:

What is GAVI?

GAVI Fact Sheets

Governance

Board Documents

Guidelines

Press Releases

Immunization Information

Immunization Forum
Latest Issue

GAVI Update

Glossary

Employment


14th GAVI BOARD MEETING
Abuja, Nigeria, 4-5 December 2004
SUMMARY REPORT

>>Back to the 14th GAVI Board Meeting

Documents
  • Norway PDF - 344K and USA PDF - 34K candidates 
  • Developing country analysis PDF - 17K
  • NGO report PDF - 82K
  • DCVMN candidate PDF - 37Kand letter PDF -195K
  • 16 Board turnover

    DECISIONS
    The Board:

      16.1 Accepted the nomination of Norway to assume the industrialized country government seat being vacated by Canada at the end of 2004. Norway, whose term will be from January 2005 to December 2007, will be represented by Norad Senior Executive Adviser Dr Sigrun Mogedal.

      16.2 Accepted the nomination of Benin, Cambodia, and Ghana to assume developing country government seats, considering that the Board has decided to increase the representation by developing countries by one seat (see section 7 on governance). Two seats are being vacated at the end of 2004 – Mongolia and Mozambique. Benin will be represented by Minister of Public Health Dr Yvette Seignon; Cambodia will be represented by Minister of Health Prof. Eng Huot; and Ghana will be represented by Minister of Health Dr K. Afriyie. To stagger turnover in the future one of the three members, chosen in consultation with the Chair, will have a term of four years instead of three.

      16.3 Accepted the nomination of the International Pediatric Association (IPA) to assume the NGO seat that was vacated by the International Federation of the Red Cross and Red Crescent Societies in July 2003. The IPA, whose term will be from January 2005 to December 2007, will be represented by the current IPA president, Dr Adenike Grange.

      16.4 Accepted the nomination of the Bio-Manguinhos/Fiocruz, Brazil to assume the developing country vaccine industry being vacated by Serum Institute of India at the end of 2004. Bio-Manguinhos/Fiocruz, whose term will be from January 2005 to December 2007, will be represented by Dr. Akira Homma, Director, Bio-Manguinhos/Fiocruz.

    >>Back to the 14th GAVI Board Meeting

    View all documents here

    View all presentations here

    Topics

    1. Presentation by Nigeria immunization programme
    2. Overview of the first phase of GAVI and The Vaccine Fund financial report
    3. Final report of the 2003 Work Plan and Interim report of the GAVI 2004-05 Work Plan
    4. ADIP Management Committee Report and Recommendations
    5. Recommendations of the Hib task force
    6. Financing
    7. ISS Extension
    8. Independent Review Committee (IRC) policy recommendations
    9. Recommendation of the governance sub-group
    10. Framework for strengthening immunization services
    11. Long-term procurement strategy
    12. Funding for innovations programme
    13. Eligible countries in phase 2
    14. Global Immunization Vision and Strategy
    15. International Finance Facility for Immunization (IFFIm)
    16. Board turnover
    star_int   Contact us | Guestbook | Copyrights | Text site